Key Metrics
8.1
CiteScore
CiteScore
CiteScore measures average citations received per document published in the serial.
1.92
SNIP
SNIP
Source Normalized Impact per Paper measures actual citations received relative to citations expected for the serial’s subject field.
Topics Covered on Drugs in Context
- Clinical trial
- Psoriasis
- Vaginal atrophy
- Postmenopausal women
- Ribavirin
- Treatment options
- Breast cancer
- Rheumatoid arthritis
- Type 2 diabetes
- Ulcerative colitis
- Type 2 Diabetes Mellitus
- Ketamine
- Janus kinase inhibitor
- Heart failure
- Atopic dermatitis
- Response analysis
- Sofosbuvir
- Sore throat
- Immunotherapy
- Psoriatic arthritis
Journal Specifications
| Overview | |
| Publisher | BioExcel Publishing Ltd |
| Language | English |
| Article Processing Charges | GBP 1550 |
| Publication Time | 9 |
| Editorial Review Process | Anonymous peer review |
| General Details | |
| Language | English |
| Website URL | Visit website |
| Publication Details | |
| Plagiarism | Visit website |
| Waiver Policy | Visit website |
| Publication Time | 9 |
| Article Processing Charges | GBP 1550 |
| Editorial Review Detail | |
| Editorial Team | Visit website |
| Review Process | Anonymous peer review |
| Review Url | Visit website |
| Information for authors | |
| Author instructions | Visit website |
| Deposit Policy | Sherpa/Romeo |
| License type | CC BY-NC-ND |
| OA statement | Visit website |
Planning to publish in Drugs in Context ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Looking for the right journals to submit your mansucript?
Upload your manuscript and get a submission readiness score and other journal recommendations.
Check my PaperRecently Published Papers
-
Full paper
Place in therapy of key treatments for platinum-sensitive, relapsed, extensive-stage small cell lung cancer with a focus on lurbinectedin: a narrative review with case studies
- 29 Oct 25
- Drugs in Context
-
Full paper
Management of refractory generalized myasthenia gravis with eculizumab during pregnancy and puerperium: a case report
- 1 Oct 25
- Drugs in Context
-
Full paper
In vitro antimicrobial activity of an oral spray combining 0.15% benzydamine hydrochloride and 0.5% cetylpyridinium chloride
- 29 Sep 25
- Drugs in Context
-
Full paper
Tezepelumab for early-onset severe allergic asthma with persistent airflow limitation and small airway dysfunction: a treatable traits approach
- 25 Sep 25
- Drugs in Context
-
Full paper
10 years of real-world data: long-term efficacy and safety of HyalOne® for hip osteoarthritis
- 19 Sep 25
- Drugs in Context
-
Full paper
Nurses’ perceptions on the usability of the Hyrimoz® Sensoready® autoinjector device
- 17 Sep 25
- Drugs in Context
Scite analysis
Powered by scite_
520 articles received 6.4k citations see all
- 127 Supporting
- 5,936 Mentioning
- 21 Contrasting
Editorial notices
- 0 Retractions
- 0 Withdrawals
- 0 Corrections
- 7 Errata
- 0 Expression of Concern
FAQs
How many articles did Drugs in Context publish last years ?
In 2024, Drugs in Context published 52 articles.
What is the eISSN & pISSN for Drugs in Context ?
For Drugs in Context,eISSN is 1740-4398 and pISSN is1745-1981.
What is Citescore for Drugs in Context ?
Citescore for Drugs in Context is 8.1.
What is SNIP score for Drugs in Context ?
SNIP score for Drugs in Context is 1.92.
Who is the publisher of Drugs in Context ?
BioExcel Publishing Ltd is the publisher of Drugs in Context.